Marshall Wace
VYGR icon

Marshall Wace’s Voyager Therapeutics VYGR Stock Holding History

Marshall Wace’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-47,808
Closed -$445K – 3003
2024
Q1 		$445K Sell
47,808
-26,935
-36% -$227K ﹤0.01% 1978
2023
Q4 		$631K Sell
74,743
-133,819
-64% -$971K ﹤0.01% 1633
2023
Q3 		$1.62M Sell
208,562
-260,715
-56% -$2.38M ﹤0.01% 1320
2023
Q2 		$5.37M Buy
469,277
+402,280
+600% +$4.16M 0.01% 989
2023
Q1 		$517K Buy
+66,997
New +$533K ﹤0.01% 2086
2022
Q4 		– Sell
-189,736
Closed -$1.12M – 3461
2022
Q3 		$1.12M Buy
+189,736
New +$1.21M ﹤0.01% 2352
2022
Q2 		– Sell
-305,445
Closed -$2.33M – 3897
2022
Q1 		$2.33M Sell
305,445
-136,436
-31% -$609K ﹤0.01% 1959
2021
Q4 		$1.2M Buy
+441,881
New +$1.51M ﹤0.01% 2386
2021
Q3 		– Sell
-21,852
Closed -$90K – 3472
2021
Q2 		$90K Sell
21,852
-10,843
-33% -$49.1K ﹤0.01% 2541
2021
Q1 		$154K Buy
+32,695
New +$223K ﹤0.01% 2313
2020
Q3 		– Sell
-95,954
Closed -$1.21M – 1954
2020
Q2 		$1.21M Sell
95,954
-98,490
-51% -$1.15M 0.01% 943
2020
Q1 		$1.78M Buy
+194,444
New +$2.23M 0.02% 664
2019
Q4 		– Sell
-42,141
Closed -$725K – 2097
2019
Q3 		$725K Buy
+42,141
New +$885K 0.01% 1015
2018
Q4 		– Sell
-58,749
Closed -$1.11M – 1831
2018
Q3 		$1.11M Buy
+58,749
New +$1.13M 0.01% 789

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Marshall Wace's VYGR Position: Q2 2024 in Review

Marshall Wace sold out of Voyager Therapeutics (VYGR) in Q2 2024, closing a stake of 47,808 shares — an estimated $445K sold.

Marshall Wace first reported a position in VYGR in Q3 2018 and held it in 14 quarters. The position peaked at $5.37M in Q2 2023. 127 funds tracked by Wall St. Rank hold VYGR as of Q2 2024.

  • Marshall Wace reported no remaining Voyager Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Marshall Wace sold 47,808 Voyager Therapeutics shares in Q2 2024, an estimated $445K.
  • Marshall Wace first reported a position in Voyager Therapeutics in Q3 2018 and held it in 14 quarters.
  • Marshall Wace's Voyager Therapeutics position peaked at $5.37M in Q2 2023.
  • 127 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2024.

Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.